Pharmacokinetics of ASP2408
4 clinical trials · Condition
◉ Watch Pharmacokinetics of ASP2408
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Safety of ASP2408 After Subcutaneous Administration to Healthy Male Subjects (NCT02140125) | Astellas Pharma Inc | 2012-08-01 |
| A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With Rheumatoid Arthritis on Methotrexate (NCT02052375) | Astellas Pharma Global Development, Inc. | 2012-06-01 |
| A Study to Evaluate a Single Intravenous (IV) Dose Using a New Manufactured Clone and Single Ascending Doses of Subcutaneous (SC) Injections (NCT02150070) | Astellas Pharma Global Development, Inc. | 2011-08-01 |
| A Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of ASP2408 Following Single Intravenous Doses in Healthy Subjects (NCT02125435) | Astellas Pharma Global Development, Inc. | 2011-01-01 |
Track Pharmacokinetics of ASP2408 automatically
Every clearance here is in the API, with alerts when new ones post.